Ignite Creation Date:
2024-05-05 @ 12:07 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00240422
Status:
COMPLETED
Last Update Posted:
2013-11-08
First Post:
2005-10-14
Brief Title:
Trial to Compare the Effects of Either Telmisartan 40-80 mg PO Once Daily or Ramipril 5-10 mg PO Once Daily on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes
Sponsor:
Organization:
Boehringer Ingelheim